SUSPENDED

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.

Official Title

Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment

Quick Facts

Study Start:2022-07-01

Study Completion:2026-12-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:SUSPENDED

Study ID

NCT03616236

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Subject must provide written informed consent prior to the conduct of any study-related procedures 2. Male or female, 18-65 years of age, inclusive 3. Be on parole or probation for at least the next 4 months 4. Have a Baltimore City address, and (5) Primary diagnosis of (DSM-5) moderate-severe opioid use disorder (at least 4 symptoms) including current use and current physiologic dependence \[Note: parolees not currently physically dependent will be allowed in the study\].	1. Current medical condition that may prevent the participant from safely participating in the study as determined by medical evaluation 2. Current psychosis or suicidal ideation 3. Cognitive disorders that prevent the participant from passing a study enrollment quiz 4. Any pending legal action that would interrupt study participation (eg, pending incarceration, probation/parole revocation, unadjudicated charges) 5. Exposure to any investigational drug within 8 weeks of screening 6. Current use benzodiazepines (such as Valium, Xanax and other sedatives), either prescribed or illicitly obtained 7. Currently enrolled in a methadone maintenance treatment program or taking long-acting naltrexone.

Inclusion Criteria

Exclusion Criteria

1. Subject must provide written informed consent prior to the conduct of any study-related procedures
2. Male or female, 18-65 years of age, inclusive
3. Be on parole or probation for at least the next 4 months
4. Have a Baltimore City address, and (5) Primary diagnosis of (DSM-5) moderate-severe opioid use disorder (at least 4 symptoms) including current use and current physiologic dependence \[Note: parolees not currently physically dependent will be allowed in the study\].

1. Current medical condition that may prevent the participant from safely participating in the study as determined by medical evaluation
2. Current psychosis or suicidal ideation
3. Cognitive disorders that prevent the participant from passing a study enrollment quiz
4. Any pending legal action that would interrupt study participation (eg, pending incarceration, probation/parole revocation, unadjudicated charges)
5. Exposure to any investigational drug within 8 weeks of screening
6. Current use benzodiazepines (such as Valium, Xanax and other sedatives), either prescribed or illicitly obtained
7. Currently enrolled in a methadone maintenance treatment program or taking long-acting naltrexone.

Contacts and Locations

Study Locations (Sites)

Division of Parole & Probation

Baltimore, Maryland, 21202

United States

Collaborators and Investigators

Sponsor: Friends Research Institute, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-01

Study Completion Date2026-12-30

Study Record Updates

Study Start Date2022-07-01

Study Completion Date2026-12-30

Terms related to this study

Additional Relevant MeSH Terms

Opioid Use